Skip to content
Insurance, Medical Health Aged Care

GMHBA offers connected health services under the one roof

GMHBA 2 mins read

Monday 31 July 2023

 

GMHBA’s first Health Hub has opened in Belmont making it easier for patients to see connected health services in a single location.

Bringing together medical, dental and physiotherapy with an adjoining pharmacy, the multi-disciplinary centre offers convenience for Geelong residents who require a range of health care providers.

Located on High Street in Belmont, the purpose-built facility features modern, contemporary designed consulting rooms and technology. There is also spacious parking and convenient access to nearby shops and public transport.

Services at the Centre are open to all local community members, not just those insured with GMHBA.

Chief Operating Officer (Health & Branch Network) Natalie Lanarus said the aim was to support patients on their health journeys and connect them with specialist services, with a focus on preventive care.

“We are thrilled to open The Hub and excited about the positive impact it will have on the health and well-being of our members and patients,” she said.

“It represents our commitment to delivering exceptional healthcare experiences and aligns with our purpose of supporting communities to live healthier lives.”

The facility is co-located with fellow Geelong not-for-profit Community Care Chemist, which will offer additional benefits to patients including access to medication, diabetes consultations, vaccinations, blood glucose testing and more.

Community Care Chemist Chief Executive Officer Nick Salkeld said the partnership was a great example of two Geelong-based organisations, working collaboratively to ensure timely access to primary health care for local patients.

“The partnership furthers opportunities for collaboration amongst health practitioners, including pharmacists, GPs, dentists and other health practitioners, improving health outcomes for patients in the region, all within the convenience of the health hub,” he said.

Bookings for The Hub can be made online at www.gmhba.com.au/gmhbahub


About us:

About us

GMHBA is an Australian not for profit health insurance and care company. We have served the community since 1934, and with 89 years’ experience, we have become Australia’s leading regionally based private health insurer. Through our personalised approach and exceptional customer service, we put the health and wellbeing of our members and communities first. Our approach is guided by our philosophy, Healthier Together and decisions are made with our members first and foremost in mind.


Contact details:

GMHBA Head of Corporate Communications Meg Rayner: 0458 418 823 or megrayner@gmhba.com.au

Media

More from this category

  • Medical Health Aged Care
  • 31/10/2024
  • 17:55
Kyowa Kirin Co., Ltd.

Kyowa Kirin Announces Changes in Top Leadership Positions to Strengthen Operations as a Global Specialty Pharmaceutical Company

Masashi Miyamoto to be named Chairman and CEO Abdul Mullick to be named President and COO Changes designed to further deliver on company’s 2030…

  • Contains:
  • Medical Health Aged Care
  • 31/10/2024
  • 12:10
MannKind

First Site Initiated in Australia for MannKind’s Phase 3 Clinical Trial Evaluating Clofazimine Inhalation Suspension for the Treatment of Nontuberculous Mycobacterial (NTM) Lung Disease

ICoN-1 study presentation planned November 1 at NTM Symposium AustraliaStudy is cleared by health authorities to proceed in Australia, U.S., Japan and South Korea, with Taiwan anticipated by end of year DANBURY, Conn., Oct. 30, 2024 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq: MNKD), a company focused on the development and commercialization of innovative inhaled therapeutic products and devices for patients with endocrine and orphan lung diseases, announced today that it has initiated its first site for its Phase 3 clinical trial evaluating efficacy and safety of Clofazimine Inhalation Suspension for the treatment of nontuberculous mycobacterial (NTM) lung disease. The study,…

  • Business Company News, Medical Health Aged Care
  • 31/10/2024
  • 11:03
Firebrick Pharma

Agreement Signed to Market Nasodine to Healthcare Professionals in Singapore

Firebrick Pharmais pleased to announce that it has executed a Marketing Representation Agreement (the “Agreement”) with Singapore-based, Innorini, trading as Innorini Life Sciences (“Innorini”). The initial term of the Agreement is one year with the option to renew for subsequent one-year terms by mutual agreement. Under the Agreement, Innorini will undertake “Marketing Services” commencing 1 November 2024. The Marketing Services comprise sampling and promotion of Nasodine® Nasal Spray (“Nasodine”) to General Practitioners (“GPs”) and hospital-based doctors and pharmacists (collectively “HCPs”) in Singapore. In addition to building awareness and support of Nasodine by HCPs, Innorini will be expected to sell Nasodine…

  • Contains:

Media Outreach made fast, easy, simple.

Feature your press release on Medianet's News Hub every time you distribute with Medianet. Pay per release or save with a subscription.